Vor Biopharma (VOR) Return on Equity (2020 - 2026)

Vor Biopharma (VOR) has 7 years of Return on Equity data on file, last reported at 0.02% in Q1 2026.

• Quarterly Return on Equity fell 5.0% year-over-year to 0.02% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.02% (down 5.0% YoY) and the FY2025 annual result came in at 0.03%, up 7.0% from the prior year.
• Return on Equity rose to 0.02% in Q1 2026 per VOR's latest filing, from 0.0% in the prior quarter.
• Across five years, Return on Equity topped out at 0.1% in Q4 2024 and bottomed at 0.01% in Q3 2024.
• The 5-year median for Return on Equity is 0.0% (2022), against an average of 0.01%.
• The widest annual swing landed in 2024, when Return on Equity rose 11 bps; it then declined 10 bps in 2025.
• Tracing VOR's Return on Equity over 5 years: stood at 0.0% in 2022, then plunged by 61 bps to 0.01% in 2023, then jumped by 1462 bps to 0.1% in 2024, then plunged by 97 bps to 0.0% in 2025, then surged by 657 bps to 0.02% in 2026.
• Per Business Quant, the three latest VOR Return on Equity figures stand at 0.02% (Q1 2026), 0.0% (Q4 2025), and 0.0% (Q3 2025).

Peer Comparison